twenty-first century cancer epidemic caused obesity involvement insulin diabetes insulin-like growth factors abstract obesity reached epidemic proportions developed world progression obesity diabetes mellitus type num metabolic syndrome recognised significant increase risk major human cancers acknowledged review molecular basis involvement morbidly high concentrations endogenous therapeutic insulin insulin-like growth factors progression obesity diabetes finally cancer epidemiological biochemical studies establish role insulin hyperinsulinaemia cancer risk progression insulin-like growth factors igf num igf num secreted visceral mammary adipose tissue significant paracrine endocrine effects effects exacerbated increased steroid hormone production structural studies elucidate ligands insulin igf num igf num interacts differently isoforms insulin receptor type igf receptor explain protagonists contribute diabetes-associated cancer inform treatment cancers arise obese individuals diabetes mellitus type num drugs target insulin insulin-like growth factor signal transduction pathways clinical trial effective biomarker-informed patient stratification implemented 
